Obexelimab (XmAb5871) is a bifunctional monoclonal antibody that binds to both CD19 and FcgammaRIIb, inhibiting the activity of B cells, plasma cells, and plasma cell precursors. Obexelimab is used in the study of autoimmune diseases such as systemic lupus erythematosus.
Reinheit:
98.00%
CAS Nummer:
[1690307-05-1]
Target-Kategorie:
Immunology/Inflammation related|||Apoptosis
T81624
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten